This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Effect of Acetylcysteine Inhalation on Incidence and Time to Develop Ventilator Associated Pneumonia in Critically Ill Mechanically Ventilated Patients | MicrobiomeTrials
← Back to trials NCT07409727
Effect of Acetylcysteine Inhalation on Incidence and Time to Develop Ventilator Associated Pneumonia in Critically Ill Mechanically Ventilated Patients Recruiting PHASE4 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-03-01Est. Completion: 2028-03
Enrollment target: 80 participantsLocations Cairo University Hospitals, Cairo, Egypt Other microbiome trials you might be interested in Acute Respiratory Distress Syndrome
China faces major challenges in the ECMO management of patients with moderate-to-severe ARDS, including substantial hete…
Beijing, China Est. completion Feb 28, 2030
Community-acquired Pneumonia
The main objective of the trial is to assess the efficacy and safety of trimodulin as adjunctive treatment to standard o…
Mobile, United States Est. completion Jul 31, 2028
Pneumonia, Viral Ventilator Associated Pneumonia Community-acquired Pneumonia Herpes Simplex Hospital-acquired Pneumonia
Almost 90 out of 100 people carry herpes simplex viruses (HSV). Once a person has been infected with the herpes viruses,…
Freiburg im Breisgau, Germany Est. completion Jul 2026